Correspondence 0001104659-24-074566 from Century Therapeutics, Inc. (IPSC) (CIK 0001850119) (IPSC)
Century Therapeutics, Inc. (IPSC) (CIK 0001850119)
Date: June 25, 2024 · CIK: 0001850119 · Accession: 0001104659-24-074566
AI Filing Summary & Sentiment
File numbers found in text: 333-280310
Letter
Century Therapeutics, Inc.
25 North 38th Street, 11th Floor
Philadelphia, Pennsylvania 19104
June 25, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Century Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 18, 2024 (File No. 333-280310)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-280310) (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:05 P.M., Eastern Time, on June 26, 2024, or as soon thereafter as is practicable.
Please contact Justin S. Platt, Esq. of Goodwin Procter LLP, counsel to the Company, at (212) 459-7340 to provide notice of effectiveness, or if you have any questions or comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours,
CENTURY THERAPEUTICS, INC.
Show Raw Text
CORRESP
1
filename1.htm
Century Therapeutics, Inc.
25 North 38th Street, 11th
Floor
Philadelphia, Pennsylvania 19104
June 25, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549-7553
Re: Century
Therapeutics, Inc.
Registration Statement on Form S-3
Filed June 18, 2024 (File No. 333-280310)
Ladies and Gentlemen:
Pursuant to Rule 461
under the Securities Act of 1933, as amended, Century Therapeutics, Inc. (the “Company”) hereby requests
that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-280310) (the “Registration
Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:05 P.M., Eastern
Time, on June 26, 2024, or as soon thereafter as is practicable.
Please contact Justin S. Platt, Esq.
of Goodwin Procter LLP, counsel to the Company, at (212) 459-7340 to provide notice of effectiveness, or if you have any questions or
comments concerning this request.
[Remainder of the page intentionally left blank]
Very truly yours,
CENTURY THERAPEUTICS, INC.
By:
/s/ Brent Pfeiffenberger, Pharm.D.
Name:
Brent Pfeiffenberger, Pharm.D.
Title:
President and Chief Executive Officer